CME Group (CME) ebitda was $4.4B in FY2025 (+7% YoY). The tables below show the complete quarterly and annual ebitda history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual EBITDA
Fiscal Year
EBITDA
YoY
2025
$4.4B
+7%
2024
$4.1B
+13%
2023
$3.6B
+13%
2022
$3.2B
+13%
2021
$2.9B
-1%
2020
$2.9B
+2%
2019
$2.8B
+0%
2018
$2.8B
+14%
2017
$2.5B
+4%
2016
$2.4B
+10%
2015
$2.2B
+11%
2014
$2.0B
+7%
2013
$1.8B
-3%
2012
$1.9B
-14%
2011
$2.2B
+10%
2010
$2.0B
+14%
2009
$1.8B
-0%
2008
$1.8B
+48%
2007
$1.2B
Recent Quarterly EBITDA
Quarter
EBITDA
Q2 2026
$1.2B
Q1 2026
$1.4B
Q4 2025
$1.1B
Q3 2025
$1.0B
Q2 2025
$1.2B
Q1 2025
$1.2B
Q4 2024
$1.0B
Q3 2024
$1.1B
Q2 2024
$1.0B
Q1 2024
$1.0B
Q4 2023
$919M
Q3 2023
$870M
Source: CME on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.